Accuramed
Accuramed is a Belgian privately held Benelux distributor of cardiorespiratory, molecular diagnostics, allergy/autoimmune, and gait analysis medical devices from premium OEMs, bundled with in-house software and full-service support to 300+ hospitals, labs, and practices.
- Company typePrivate
- Founded2000
- HeadquartersHalen, Belgium
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Accuramed does
Accuramed BV is a privately held Belgian medical device and diagnostics distributor headquartered in Halen, Belgium, operating across the Benelux region (Belgium, Netherlands, Luxembourg). Founded in 2000 by Jozef Knez and now led by co-CEOs Filip and Karel Knez, the company assembles 'best-of-brands' solutions from premium third-party manufacturers across cardiorespiratory testing (NIOX Vero FeNO device, Geratherm pulmonary function equipment), molecular diagnostics (Seegene Allplex syndromic PCR panels, USTAR EasyNAT point-of-care platform), allergy and autoimmune testing (AliveDx MosaiQ microarray and LumiQ IFA systems), fecal screening, and movement/gait analysis. Accuramed complements distributed products with proprietary in-house software (SG STATS for statistical analytics of Seegene panels, Accuranalysis for interpretation of non-Seegene assays) and offers an end-to-end A-to-Z service model covering needs analysis, installation, validation, training, technical support, and application support managed by internal specialists through a central Service Desk.
The company serves more than 300 practices and laboratories across the Benelux, with primary customer segments in hospitals and clinical laboratories (molecular diagnostics, immunology, fecal screening), pneumology and cardiology practices (cardiopulmonary function testing, FeNO measurement), and a secondary segment in sports medicine and rehabilitation (CPET, gait analysis). Revenue is generated through a mix of equipment sales, recurring consumables and assays, and associated service contracts, with direct field sales across all three Benelux countries. Since June 2024, with a minority investment from private equity firm Down2Earth Capital (D2E), Accuramed has pursued an active roll-up strategy, completing five acquisitions (Segers Medical Systems, Clindia Benelux BV, MML Medical B.V., BeMedico NV, and PT Medical) to broaden its product portfolio and geographic scale. The company holds ISO 9001:2015 certification and was named NIOX 'Distributor of the Year' in 2025.
Accuramed firmographics
Firmographics- Name
- Accuramed
- Legal name
- Accuramed BV
- Website
- https://accuramed.be
- Company type
- Private
- Founded year
- 2000
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Accuramed is a Belgian privately held Benelux distributor of cardiorespiratory, molecular diagnostics, allergy/autoimmune, and gait analysis medical devices from premium OEMs, bundled with in-house software and full-service support to 300+ hospitals, labs, and practices.
- Ownership category
- akta.pro rank
Accuramed industry classification
Industry- Product category
- Medical Device Distribution
- NAICS
- Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers (423450), Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers (42345), Drugs and Druggists' Sundries Merchant Wholesalers (42421)
- SIC
- Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047), In Vitro & In Vivo Diagnostic Substances (2835)
- akta.pro primary industry
- Quality Control, Calibrators, Standards & Proficiency Testing (IVD Consumables) (HLAHAAAL)
Keywords
Where Accuramed is headquartered
LocationHeadquarters
- HQ city
- Halen
- HQ country
- Belgium
- HQ region
- Europe
Offices1 record
Markets served
Accuramed business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Supply Chain, Operations, Marketing or Sales, Technology or R&D, Infrastructure
Revenue model
- Medical Device and Diagnostics Distribution: Accuramed acts as a Benelux distributor of cardiorespiratory testing devices and laboratory diagnostic equipment. Solutions are composed from premium third-party manufacturers across multiple brands, supplemented by Accuramed's own hardware and software developments. Revenue is generated through the sale of equipment, consumables, assays, and associated services including installation, validation, training, and technical support.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels4 records
Accuramed product offering
Product offeringCore offering
Accuramed is a Benelux medical device and in-vitro diagnostics distributor that assembles tailored, multi-vendor solutions from premium third-party manufacturers. The portfolio spans molecular diagnostics (syndromic multiplex PCR), immunofluorescence (IFA), allergy and autoimmune microarrays, turbidimetric fecal screening, cardio-respiratory function testing, and movement/gait analysis. These distributed offerings are supplemented by Accuramed's own in-house hardware and software developments (e.g., SG STATS, Accuranalysis) and backed by an A-to-Z service model covering analysis, installation, validation, training, and ongoing technical and application support.
Product overview
Accuramed provides a portfolio of distributed medical diagnostic products and in-house developed software solutions. The core offerings include molecular diagnostics (Allplex syndromic PCR panels, USTAR EasyNAT point-of-care platform), allergy and autoimmune testing (AliveDx MosaiQ microarray platform, AliveDx LumiQ IFA automation), respiratory diagnostics (NIOX Vero FeNO device), and fecal screening solutions. These products are complemented by proprietary software tools including Accuranalysis (result interpretation) and SG STATS (statistical analysis for Seegene panels). The company operates as a multi-vendor distributor across Benelux, combining third-party products with in-house IT developments and comprehensive service support from analysis to aftercare.
Differentiator
Problem solved
Functional benefit
Brands
- Clindia: Acquired brand focusing on niche in vitro diagnostic products including rapid tests, analyzers and diagnostic tools for clinical chemistry, hematology, microbiology
Products and services
- AliveDx MosaiQ Fully automated, high-throughput multiplex microarray platform combining sample processing and microarray detection for autoimmune disease and allergy testing. Supports walkaway time greater than 7 hours, first result under 1 hour, and throughput of 85 samples/hour with up to 30+ analytes per panel. Sold to hospital and clinical laboratory customers in the Benelux.
- AliveDx LumiQ Benchtop, all-in-one immunofluorescence (IFA) automation platform combining processing and reading without manual intervention. Supports up to 216 samples per run, up to 27 slides from different tests simultaneously, positive/negative pre-classification, and pattern recognition. Sold to hospital and clinical laboratory customers in the Benelux.
- NIOX Vero Portable Fractional Exhaled Nitric Oxide (FeNO) measurement device for asthma management, conformant to ERS guidelines, with audiovisual patient guidance and Bluetooth connectivity for automated reporting. Sold to pneumology, allergy, and primary care practices in the Benelux.
- Allplex MDRO Assay Multiplex real-time PCR assay for simultaneous detection of 4 high-risk healthcare-associated pathogens and 7 resistance genes in a single test, enabling efficient mapping of complex resistance profiles. Sold to hospital and clinical laboratory customers in the Benelux.
- MosaiQ AiPlex CD Multiplex microarray panel for celiac disease diagnosis detecting Total IgA, tissue transglutaminase (tTG) IgA/IgG, and deamidated gliadin peptide (DGP) IgA/IgG from serum. Run on the AliveDx MosaiQ platform. Sold to hospital and clinical laboratory customers in the Benelux.
- MosaiQ AiPlex CTDplus Multiplex microarray panel for connective tissue disease detection covering dsDNA, SS-A 60, SS-A 52, SS-B, Sm, Sm/RNP, U1RNP, Jo-1, Scl-70, CENP B, Chromatine, Ribosomal P Protein, DFS70, RNA Pol III, and CCP2. Run on the AliveDx MosaiQ platform. Sold to hospital and clinical laboratory customers in the Benelux.
- MosaiQ AiPlex VAS Multiplex microarray panel for vasculitis detection including Anti-Myeloperoxidase (Anti-MPO) IgG, Anti-Proteinase 3 (Anti-PR3) IgG, and Anti-GBM IgG. Run on the AliveDx MosaiQ platform. Sold to hospital and clinical laboratory customers in the Benelux.
- LumiQ Diagnostic Kit for Anti-dsDNA IgG (IFA) Diagnostic kit for qualitative detection of anti-dsDNA IgG in human serum, used as an aid in the diagnosis of systemic lupus erythematosus (SLE) with positive/negative pre-classification. Run on the AliveDx LumiQ platform. Sold to hospital and clinical laboratory customers in the Benelux.
- LumiQ Diagnostic Kit for ANA (IFA) Diagnostic kit for qualitative determination of auto-antibodies against nucleus and other components in human serum, supporting diagnosis of connective tissue diseases including SLE, Sjögren's syndrome, and systemic sclerosis. Run on the AliveDx LumiQ platform. Sold to hospital and clinical laboratory customers in the Benelux.
- USTAR EasyNAT Point-of-care molecular platform for isothermal nucleic acid detection. Processes up to 4 samples simultaneously with IVD menu including MPOX, GBS, COVID, Malaria, HSV1/2, MP, and BP detection. Features magnetic bead extraction and ready-to-use reagent cartridges. Sold to hospital, laboratory, and clinical customers in the Benelux.
- Accuranalysis In-house developed software for interpreting molecular diagnostic results. Allows tests not available in the Seegene portfolio to be run on the familiar open platform, with quantitative or qualitative interpretation, calibration curve storage, robust interpretation algorithm, and data export. Provided as part of the molecular diagnostics solution bundle to clinical laboratory customers.
- SG STATS In-house developed statistical data analysis software for Seegene syndromic panels. Monitors target prevalence, combinations, and trends over selected periods, automatically integrates data from Seegene Viewer, tracks mean Ct values per patient down to reagent lot level, and monitors internal control results for QC tracking. Provided as part of the molecular diagnostics solution bundle to clinical laboratory customers.
Quantifiable outcome
- Over 300 practices and laboratories across the Benelux rely on Accuramed solutions
- +2 more outcomes
Companies that use Accuramed
Customer profileNamed customers2 records
Segments3 records
Ideal customer profiles3 records
Accuramed technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration5 records
Feature6 records
Accuramed partnerships and signals
Strategic signalPartnerships
Nine partnerships are on record, tiered minor and core.
- MML Medical B.V.minorAccuramed announced the acquisition of MML Medical B.V., further expanding its distribution capabilities and product portfolio in the Benelux medical device market.
- Clindia Benelux BVminorAccuramed acquired Clindia Benelux BV, a Dutch company specializing in niche in vitro diagnostic products including rapid tests, analyzers, and diagnostic tools for clinical chemistry, hematology, and microbiology labs. The acquisition strengthens Accuramed's market position in the Benelux distribution of medical products.
- BeMedico NVminorAccuramed announced the acquisition of BeMedico NV, expanding its portfolio of medical diagnostic and device solutions in the Benelux market.
- PT MedicalminorAccuramed announced the acquisition of PT Medical, adding to its growing portfolio of medical device and diagnostic solutions in the Benelux region.
- Segers Medical SystemsminorAccuramed integrated the product portfolio of Segers Medical Systems, previously represented by Eric Segers, into its own portfolio. The acquisition added RT-PCR kits from Mikrogen Diagnostik, Ingenetix, and PSS, and expanded the company's automation options with PSS, magLEAD, and GeneLead extraction and amplification solutions. Eric Segers joined the Accuramed team to ensure continuity of support.
- SeegenecoreAccuramed partnered with Seegene in 2016 to introduce automated molecular diagnostics and syndromic PCR testing (respiratory infections, GI diseases, STIs) to the Benelux market. Seegene's innovative automated solution enabled Accuramed to become a key player in the molecular diagnostics market. The partnership also includes participation in Seegene's Open Innovation Program and MDx Impact Grants for developing new syndromic panels.
- NIOX Group PlccoreNIOX Group Plc is a key manufacturing partner whose products (including the Niox Vero FeNO device) Accuramed distributes across the Benelux. Accuramed was recognized as 'Distributor of the Year' by NIOX in 2025. The partnership has been a cornerstone of Accuramed's cardiorespiratory division since the company's founding.
- Geratherm Respiratory GmbHcoreGeratherm Respiratory GmbH is a key product partner supplying cardiopulmonary function testing equipment that Accuramed distributes across the Benelux as part of its 'best-of-brands' portfolio approach.
- AliveDxcoreAccuramed distributes AliveDx products including the MosaiQ automated multiplex microarray platform and LumiQ fully automated IFA system for allergy and autoimmune disease diagnostics. These products provide complete and efficient solutions for auto-immune and allergy testing in the Benelux.
Scale indicators6 records
Recent moves7 records
Expansion highlights5 records
Accuramed competitors and assessment
Company assessmentDirect peers
- ELITech Group: European IVD company that both manufactures and distributes specialty clinical chemistry, microbiology, and molecular diagnostics products. Comparable in offering IVD consumables and instruments through a regional specialty distribution channel with technical/service support to clinical labs.
- AddVision: Dutch specialty distributor of medical devices and diagnostic products serving the Benelux market. Closely comparable in go-to-market model (specialty medical distribution with direct sales and service support) and overlapping customer base of hospitals and labs in the same region.
Broad incumbents
- Henry Schein: Global Fortune 500 distributor of medical, dental, and veterinary supplies and equipment serving office-based practitioners, labs, and hospitals. Comparable as a multi-line medical distribution business model but operating at vastly larger scale across multiple geographies.
- Sebia: France-headquartered specialty IVD company focused on protein electrophoresis, capillary electrophoresis, and immunotyping for clinical diagnostics. Comparable as a European specialty IVD provider to clinical labs with technical support and dedicated distribution across multiple European countries.
- Medline Industries: One of the world's largest privately held manufacturers and distributors of medical supplies and clinical solutions. Comparable business model as a multi-line medical product distributor to hospitals and labs, but at substantially larger scale and broader portfolio.
- DiaSorin: Italian-headquartered global IVD company specializing in immunodiagnostics and molecular diagnostics. Comparable in specialty IVD categories relevant to Accuramed's molecular diagnostics, allergy, and autoimmune testing franchises, though operates at much larger scale as a manufacturer.
- Sarstedt: German-headquartered manufacturer and distributor of medical devices, laboratory consumables, and transfusion medicine products with broad European distribution. Comparable as a long-established European medical device/IVD consumables supplier with direct sales to hospitals and clinical labs.
- BioMérieux: French-headquartered global leader in in vitro diagnostics for clinical and industrial applications. Comparable in IVD product categories Accuramed distributes (molecular diagnostics, immunoassays, microbiology) but operates as a manufacturer rather than a value-added distributor.
Emerging players
- R-Biopharm: German specialty IVD company providing clinical diagnostics and food/feed testing reagents and instruments. Comparable in offering specialty IVD kits and instruments distributed through regional channels into clinical labs, particularly for molecular and immunology testing.
Regional players
- Medison Pharma: Israel-headquartered specialty pharmaceutical and diagnostics distributor serving EMEA with a partnership-led go-to-market model. Comparable business model of distributing specialty third-party medical products (including diagnostics) across multiple European geographies with a focus on rare/specialty segments.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Accuramed social profiles
Digital presenceAccuramed compliance and trust
Trust signalCompliance1 record
Accuramed financial estimates
Financial estimateRevenue estimate
Valuation estimate
Accuramed leadership team
Management profileNumber of profiles
Profiles4 records
Accuramed subsidiaries and ownership
Company hierarchySubsidiaries4 records
Accuramed funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Accuramed M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Accuramed
What does Accuramed do?
Accuramed is a Benelux medical device and in-vitro diagnostics distributor that assembles tailored, multi-vendor solutions from premium third-party manufacturers. The portfolio spans molecular diagnostics (syndromic multiplex PCR), immunofluorescence (IFA), allergy and autoimmune microarrays, turbidimetric fecal screening, cardio-respiratory function testing, and movement/gait analysis. These distributed offerings are supplemented by Accuramed's own in-house hardware and software developments (e.g., SG STATS, Accuranalysis) and backed by an A-to-Z service model covering analysis, installation, validation, training, and ongoing technical and application support.
Is Accuramed a public or private company?
Accuramed is a private company. It is classified as private equity controlled and is currently operating.
When was Accuramed founded?
Accuramed was founded in 2000. It employs 11 to 50 people.
Where is Accuramed based?
Accuramed is headquartered in Halen, Belgium, in the Europe region.
How does Accuramed make money?
One revenue line is on record: medical Device and Diagnostics Distribution.
Who are Accuramed's main competitors?
Direct peers on record are ELITech Group and AddVision. Broad incumbents are Henry Schein, Sebia, Medline Industries, DiaSorin, Sarstedt and BioMérieux. R-Biopharm is listed as an emerging player. Medison Pharma is listed as a regional player.
Does Accuramed have an API?
No public API is recorded for Accuramed.
What industry is Accuramed in?
Accuramed's product category is Medical Device Distribution. Its primary akta.pro industry code is HLAHAAAL, Quality Control, Calibrators, Standards & Proficiency Testing (IVD Consumables). Its NAICS code is 423450 and its SIC code is 5047.